Drugs / Penn Microbiome Therapy - 001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03970200 | Jan 2020 → Nov 2021 | Clostridium difficile colitis | University of Pennsylvania | Terminated | No outcome recorded |
| Phase 2 | NCT03973697 | Jan 2020 → Aug 2021 | Clostridium difficile colitis | University of Pennsylvania | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Penn Microbiome Therapy - 001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03973697 ↗ |
| Route | Rectal | “given through the rectum by an enema (lower delivery).” NCT03970200 ↗ |